With grant funding from governments at multiple levels in Canada, Entos Pharmaceuticals is looking to plant roots at a CAD $198.5 million ($137.2 million) R&D and manufacturing hub in Edmonton. | The ...

Novo Nordisk plans to offer its Wegovy weight loss drug at a reduced cost of $499 per month for cash-paying customers in the ...

Turning back to Canada, Ryan Bushell ... 32 Headquartered in Paris, France, Sanofi (NASDAQ:SNY) is a global healthcare company providing therapeutic solutions for diabetes, cardiovascular diseases ...

according to Sanofi. It has also been approved to date in the EU, GB, and Canada. New data from the phase 3b, real-world HARMONIE study has confirmed the efficacy of Beyfortus in clinical trials ...

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates ...

We recently published a list of 10 Best Immunology Stocks To Buy Now. In this article, we are going to take a look at where ...

Sanofi has moved ahead with plans to challenge ... MSD (known as Merck & Co in the US and Canada), meanwhile, recorded $647 million with its rival conjugate vaccine Vaxneuvance and another $ ...

South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...

Zacks Research cut their Q2 2025 EPS estimates for shares of Sanofi in a research report issued on Wednesday, February 19th. Zacks Research analyst K. Shah now forecasts that the company will post ...

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines.